Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma

Table 4

First-line systemic therapy regimens and median time to treatment failure (TTF).

Systemic therapy		Median TTF (months)
Gemcitabine + docetaxel	31	5.2
Gemcitabine	12	4.3
Doxorubicin-alkylator combo	20	3.1
Liposomal doxorubicin	12	2.9
Doxorubicin	6	3.3
Alkylator, single	3	1.8
Tyrosine kinase inhibitors	7	9.3
Other combos	13	7.2
Other single agents	9	1.6